Aurora A antibody
Quick Overview for Aurora A antibody (ABIN2477554)
Target
See all Aurora A (AURKA) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Cross-Reactivity
- Mouse (Murine)
-
Characteristics
- Purified IgG
-
Purification
- Purified
-
Isotype
- IgG2b
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.0 mg/mL
-
-
-
: "Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target." in: Leukemia, Vol. 27, Issue 3, pp. 560-8, (2013) (PubMed).
: "Inhibiting Polo-like kinase 1 causes growth reduction and apoptosis in pediatric acute lymphoblastic leukemia cells." in: Haematologica, Vol. 98, Issue 10, pp. 1539-46, (2013) (PubMed).
: "Preparation and characterization of a human aurora-A kinase monoclonal antibody." in: Molecular and cellular biochemistry, Vol. 243, Issue 1-2, pp. 123-31, (2003) (PubMed).
-
: "Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target." in: Leukemia, Vol. 27, Issue 3, pp. 560-8, (2013) (PubMed).
-
- Aurora A (AURKA) (Aurora Kinase A (AURKA))
-
Alternative Name
- AURORA-A KINASE
-
Background
- Synonyms: SERINE/THREONINE KINASE 15
-
Gene ID
- 6790
-
UniProt
- O14965
-
Pathways
- Cell Division Cycle, Asymmetric Protein Localization
Target
-